Natera, Inc. (NTRA)

USD 156.66

(3.5%)

Total Liabilities Summary of Natera, Inc.

  • Natera, Inc.'s latest annual total liabilities in 2023 was 691.79 Million USD , up 0.45% from previous year.
  • Natera, Inc.'s latest quarterly total liabilities in 2024 Q2 was 680.46 Million USD , up 0.95% from previous quarter.
  • Natera, Inc. reported annual total liabilities of 688.73 Million USD in 2022, up 18.1% from previous year.
  • Natera, Inc. reported annual total liabilities of 583.18 Million USD in 2021, up 30.78% from previous year.
  • Natera, Inc. reported quarterly total liabilities of 674.09 Million USD for 2024 Q1, down -2.56% from previous quarter.
  • Natera, Inc. reported quarterly total liabilities of 691.79 Million USD for 2023 FY, up 0.45% from previous quarter.

Annual Total Liabilities Chart of Natera, Inc. (2023 - 2012)

Historical Annual Total Liabilities of Natera, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 691.79 Million USD 0.45%
2022 688.73 Million USD 18.1%
2021 583.18 Million USD 30.78%
2020 445.91 Million USD 46.71%
2019 303.94 Million USD 28.79%
2018 236 Million USD 24.78%
2017 189.14 Million USD 81.52%
2016 104.2 Million USD 29.49%
2015 80.47 Million USD -72.72%
2014 294.95 Million USD 27.56%
2013 231.23 Million USD 66.47%
2012 138.9 Million USD 0.0%

Peer Total Liabilities Comparison of Natera, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -1619.778%
Applied DNA Sciences, Inc. 8.77 Million USD -7779.998%
Aspira Women's Health Inc. 8.62 Million USD -7918.987%
Biodesix, Inc. 94.51 Million USD -631.937%
BioNexus Gene Lab Corp. 1.74 Million USD -39614.204%
bioAffinity Technologies, Inc. 3.36 Million USD -20450.712%
bioAffinity Technologies, Inc. 3.36 Million USD -20450.712%
Bionano Genomics, Inc. 118.24 Million USD -485.045%
CareDx, Inc 223.28 Million USD -209.825%
Check-Cap Ltd. 1.33 Million USD -51914.887%
Castle Biosciences, Inc. 86.54 Million USD -699.378%
DarioHealth Corp. 38.24 Million USD -1708.859%
Exact Sciences Corporation 3.32 Billion USD 79.2%
Fulgent Genetics, Inc. 139.82 Million USD -394.767%
Guardant Health, Inc. 1.62 Billion USD 57.499%
ICON Public Limited Company 7.74 Billion USD 91.073%
IDEXX Laboratories, Inc. 1.77 Billion USD 61.034%
Illumina, Inc. 4.36 Billion USD 84.155%
Intelligent Bio Solutions Inc. 5.59 Million USD -12263.091%
iSpecimen Inc. 6.07 Million USD -11281.888%
Standard BioTools Inc. 159.86 Million USD -332.739%
MDxHealth SA 121.92 Million USD -467.401%
23andMe Holding Co. 206.64 Million USD -234.773%
Medpace Holdings, Inc. 1.09 Billion USD 36.988%
Myriad Genetics, Inc. 312.9 Million USD -121.092%
Mainz Biomed B.V. 12.15 Million USD -5589.221%
ENDRA Life Sciences Inc. 1.09 Million USD -63068.842%
NeoGenomics, Inc. 739.69 Million USD 6.475%
Neogen Corporation 1.44 Billion USD 51.959%
Inotiv, Inc. 588.04 Million USD -17.645%
OPKO Health, Inc. 622.47 Million USD -11.136%
Psychemedics Corporation 6.59 Million USD -10384.965%
Prenetics Global Limited 44.01 Million USD -1471.795%
Prenetics Global Limited 44.01 Million USD -1471.795%
Precipio, Inc. 3.67 Million USD -18739.815%
Personalis, Inc. 95.65 Million USD -623.199%
RadNet, Inc. 2.07 Billion USD 66.634%
Sera Prognostics, Inc. 25.28 Million USD -2636.218%
Sotera Health Company 2.68 Billion USD 74.251%
Neuronetics, Inc. 81.64 Million USD -747.366%
Star Equity Holdings, Inc. 21.67 Million USD -3091.686%
Star Equity Holdings, Inc. 21.67 Million USD -3091.686%
Trinity Biotech plc 83.38 Million USD -729.653%
Twist Bioscience Corporation 152.97 Million USD -352.241%
Exagen Inc. 34.25 Million USD -1919.848%